Anaplastic thyroid carcinoma: A therapeutic dilemma

Yonsei Medical Journal

Volumn 46, Issue 6, 2005, Pages 759-764

  Chang, Hang Seok ^a   Nam, Kee Hyun ^a   Chung, Woung Youn ^a   Park, Cheong Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Anaplastic thyroid cancer; Treatment modalities; Treatment outcome

Indexed keywords

BLEOMYCIN; BONE MORPHOGENETIC PROTEIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; HISTONE DEACETYLASE INHIBITOR; IMATINIB; INTERLEUKIN 6; MITOMYCIN; ONYX 015; PACLITAXEL; RETINOIC ACID; THYROID PEROXIDASE;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; HUMAN; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RETROSPECTIVE STUDY; THYROID CARCINOMA; THYROID SURGERY; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 30644458091     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2005.46.6.759     Document Type: Article

References (29)

1. Ain KB. Anaplastic thyroid carcinoma: a therapeutic challenge. Semin Surg Oncol l999;16:64-9.
2. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997;79:564-73.
3. Us-Krasovec M, Golouh R, Auerperg M, Besic N, Ruparcic-Oblak L. Anaplastic thyroid carcinoma in fine needle aspirates. Acta Cytol 1996;40:953-8.
4. Demeter JG, De Jong SA, Lawrence AM, Paloyan E. Anaplastic thyroid carcinoma: risk factors and outcome, Surgery 1991;110:956-61; discussion 961-3.
5. Tallroth E, Wallin G, Lundwell G, Lowhagen T, Einhorn J. Multimodal treatment in anaplastic giant thyroid carcinoma. Cancer 1987;60:1428-31.
6. Kim JH, Leeper RD. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 1987;60:2372-5.
7. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Progrnostic factors. and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 2001;25:617-22.
8. Pacheco-Ojeda LA, Martinez AL, Alvarez M. Anaplastic thyroid carcinoma in ecuador: analysis of prognostic factors. Int Surg 2001;86:117-21.
9. Pasieka JL. Anaplastic thyroid cancer. Curr Opin Oncol 2003;15:78-83.
10. Farnebo L, Tash O, Wallin G. Anaplastic giant cell carcinoma of the thyroid In: vanHeerden JA, editor. Common problems in endocrine surgery. London: Yearbook; 1989. p.33-4.
11. Kobayashi T, Asakawa H, Umeshita K, Takeda T, Maruyama H, Matsuzuka F, et al. Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck 1996;18:36-41.
12. Haigh PI. Anaplastic thyroid carcinoma. Curr Treat Options Oncol 2000;1:353-7.
13. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Geopfert H, Samaan NA. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 1990;66:321-30.
14. Tan RK, Finley RK 3rd, Driscoll D, Bakamjian V, Hicks WL Jr, fShedd DP. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 1995;17:41-7; discussion 47-8.
15. Haigh PI, Ituarte PH, Wu HS,Treseler PA, Posner MD, Quivey JM, et at. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001;91:2335-42.
16. Nilsson O, Undeberg J, Zedenius J, Ekman E, Tennvall J, Blomgren H, et al. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg 1998;92:725-30.
17. Kim HY, Chung KW, Kim HW, Youn YK, Oh SK. Clinical analysis of anaplastic thyroid carcinoma. J Korean Surg Soc 2001;61:142-7.
18. Lu WT, Lin JD, Huang HS, Chao TC. Does surgery improve the survival of patients with advanced anaplastic thyroid carcinoma? Otolaryngol Head Neck Surg 1998; 118:728-31.
19. Giuffrida D, Gharib H. Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol 2000;11: 1083-9.
20. Schlumberger M, Parmentier C, Delisle MJ, Couette JE, Droz JP, Sarrazin D. Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer 1991;67: 564-6.
21. Tennvall J, Lundell G, Hallquist A, Wahlberg P, Wallin G, Tibblin S. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group. Cancer 1994;74:1348-54.
22. Junor EJ, Paul J, Reed NS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 1992;18:83-8.
23. Lo CY, Lam KY, Wan KY. Anaplastic carcinoma of the thyroid. Am J Surg 1999;177:337-9.
24. Rosen IB, Asa SL, Brierley JD. Anaplastic carcinoma of the thyroid gland In: Clark Oh, Duh QY, Kebebew E, editors. Textbook of Endocrine Surgery. 2nd ed. Philadelphia: W.B.Saunders; 2005. p.159-67.
25. Franzen A, Heldin NE. BMP-7 induced cell cycle arrest of anaplastic thyroid carcinoma via p21(CIP1) and p27 (KIPI). Biochem Biophys Res Commun 2001;285:773-81.
26. Greenberg VL, Wiliams JM, Cogswell JP, Mendenhall M, Zimmer SG. Histone deacetylase inhibitors promote apoptosis in differential cell cycle arrest in anaplastic thyroid cells. Thyroid 2001;11:315-25.
27. Shi Y, Parhar RS, Zou M, Baitei E, Kessie G, Farid NR, et al. Gene therapy of anaplastic thyroid carcinoma with single-chain interleukin-12 fusion protein. Hum Gene Ther 2003;14:1741-51.
28. Simon D, Koehrle J, Reiners C, Boerner AR, Schmutzler C, Mainz K, et al. Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma. World J Surg 1998;22:569-74.
29. Gruning T, Tiepolt C, Zophel K, Bredow J, Kropp J, Franke WG. Retinoic acid for redifferentiation of thyroid cancer-does it hold its promise? Eur J Endocrinol 2003;148:395-402.